Lessons from Zymergen's failed Hyaline product

November 02, 2022 | Case Study

Zymergen was founded in 2013, based on a promising machine-learning platform that allowed the company to rapidly engineer microbial strains for different chemical and material targets. By 2018, the company had raised nearly USD 600 million from those believing it could significantly improve the economics of its partners' existing microbial strains and deliver new products to market. The company's first stand-alone product was a polyimide film, called Hyaline, co-developed with Sumitomo Chemical. Launched at the end of 2020, the long-anticipated product was not the success Zymergen hoped it would be.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978